- Home
- FOA vs TRDA Comparison
FOA vs TRDA Comparison
Compare FOA & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOA
- TRDA
- Stock Information
- Founded
- FOA 2013
- TRDA 2016
- Country
- FOA United States
- TRDA United States
- Employees
- FOA N/A
- TRDA N/A
- Industry
- FOA Finance Companies
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- FOA Finance
- TRDA Health Care
- Exchange
- FOA Nasdaq
- TRDA Nasdaq
- Market Cap
- FOA 248.8M
- TRDA 264.5M
- IPO Year
- FOA N/A
- TRDA 2021
- Fundamental
- Price
- FOA $22.93
- TRDA $6.40
- Analyst Decision
- FOA Buy
- TRDA Strong Buy
- Analyst Count
- FOA 2
- TRDA 3
- Target Price
- FOA $27.50
- TRDA $25.67
- AVG Volume (30 Days)
- FOA 104.1K
- TRDA 152.9K
- Earning Date
- FOA 08-05-2025
- TRDA 08-12-2025
- Dividend Yield
- FOA N/A
- TRDA N/A
- EPS Growth
- FOA N/A
- TRDA N/A
- EPS
- FOA 3.94
- TRDA 0.61
- Revenue
- FOA $429,184,000.00
- TRDA $172,220,000.00
- Revenue This Year
- FOA $21.89
- TRDA N/A
- Revenue Next Year
- FOA $8.91
- TRDA N/A
- P/E Ratio
- FOA $5.86
- TRDA $10.48
- Revenue Growth
- FOA 155.35
- TRDA 5.74
- 52 Week Low
- FOA $6.13
- TRDA $6.29
- 52 Week High
- FOA $32.40
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- FOA 54.57
- TRDA 40.89
- Support Level
- FOA $22.75
- TRDA $6.48
- Resistance Level
- FOA $24.17
- TRDA $7.62
- Average True Range (ATR)
- FOA 0.74
- TRDA 0.37
- MACD
- FOA -0.03
- TRDA -0.00
- Stochastic Oscillator
- FOA 61.94
- TRDA 20.26
About FOA Finance of America Companies Inc.
Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.